Deep Brain Stimulation (DBS) Retrospective Outcomes Study
Study Details
Study Description
Brief Summary
The primary objective of this study is to characterize real-world clinical outcomes of Deep Brain Stimulation (DBS) using retrospective review of de-identified patient records.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
The purpose of this study is to characterize
- real-world clinical outcomes of Deep Brain Stimulation (DBS) using retrospective review of de-identified patient records.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Parkinson's Disease Subjects with Parkinson's disease, implanted with a Boston Scientific Deep Brain Stimulation System |
Device: Deep Brain Stimulation
Deep Brain Stimulation in patients with Parkinson Disease, Dystonia and Essential Tremor.
|
Essential Tremor Subjects with Essential Tremor, implanted with a Boston Scientific Deep Brain Stimulation System |
Device: Deep Brain Stimulation
Deep Brain Stimulation in patients with Parkinson Disease, Dystonia and Essential Tremor.
|
Dystonia Subjects with dystonia, implanted with a Boston Scientific Deep Brain Stimulation System |
Device: Deep Brain Stimulation
Deep Brain Stimulation in patients with Parkinson Disease, Dystonia and Essential Tremor.
|
Outcome Measures
Primary Outcome Measures
- Mean Change in Unified Parkinson's Disease Rating Scale (UPDRS III) at up to 5 years post implant compared to baseline [5 yrs. post implant]
Improvement in disease symptoms as assessed by Unified Parkinson's Disease Rating Scale (UPDRS III) at up to 5 years post implant compared to baseline
Eligibility Criteria
Criteria
Inclusion Criteria:
- Must be previously treated with or eligible for implantation with a deep brain stimulation system
Exclusion Criteria:
- No Exclusion Criteria
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | St. Joseph's Hospital & Medical Center | Phoenix | Arizona | United States | 85013 |
2 | The Regents of the University of California, San Francisco campus | San Francisco | California | United States | 94143 |
3 | University of Miami Hospital | Miami | Florida | United States | 33136 |
4 | University of South Florida | Tampa | Florida | United States | 33612 |
5 | St. Luke's Regional Medical Center | Boise | Idaho | United States | 83712 |
6 | Albany Medical Center | Albany | New York | United States | 12208 |
7 | Wake Forest University School of Medicine | Winston-Salem | North Carolina | United States | 27157 |
8 | Allegheny General Hospital | Pittsburgh | Pennsylvania | United States | 15212 |
9 | Swedish Neuroscience Institute | Seattle | Washington | United States | 98122 |
10 | AZ St. Lucas | Gent | Belgium | ||
11 | AZ Delta | Roeselare | Belgium | ||
12 | Uniklinikum Jena | Jena | Germany | ||
13 | Uniklinik Köln | Köln | Germany | ||
14 | Universitaetsklinikum Schleswig-Holstein | Lübeck | Germany | ||
15 | Universitaetsklinikum Wuerzburg | Würzburg | Germany |
Sponsors and Collaborators
- Boston Scientific Corporation
Investigators
- Study Director: Roshini Jain, Boston Scientific Neuromodulation Corporation
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- A4170